SEC Form 4 · accession 0000899243-16-013528
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles L Pope
Director
Period of report
Feb 16, 2016
Accepted (ET)
Feb 17, 2016 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 16, 2016 | A | 40,000 | $0.00 | A | 201,063 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Option (Right to Buy)F2 | $0.84 | Feb 16, 2016 | A | 80,000 | A | Feb 16, 2017 | Feb 16, 2026 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2016.
- F2Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest equally over two years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 16, 2016.